Clinical Trial Update: Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating intravenous Biapenem RPX2003 and RPX7009, alone and in combination, in healthy volunteers and individuals with bacterial infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Biapenem (Biapenem)
• RPX7009

Snippet

Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | Conditions: Healthy Volunteers, Bacterial Infections | Phase 1 | Status: COMPLETED